Hemoglobin Monitoring: Potential for Novel, Non-Invasive Technology
A Survey of One Hundred Twenty Physicians
Price: $2500
Deliverable: Survey with key findings.
STUDY DESCRIPTION
|
Topic |
Market potential for a novel continuous, non-invasive hemoglobin monitoring system |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Critical care medicine, emergency medicine, internal medicine – hospitalists, anesthesiology, general surgery |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 10 minutes Size: 120 respondents Fielding Dates: September 18, 2008 to September 22, 2008 |
OBJECTIVES
To gauge the market potential for Masimo’s continuous, non-invasive hemoglobin monitoring system
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Masimo |
MASI |
Rainbow Set technology products |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria |
§ Board-certified anesthesiologists, critical care physicians, emergency room physicians, general surgeons, and hospitalists § In practice between 2 and 30 years § Spends at least 75% of professional time in clinical practice |
For additional information on this study or to purchase, please contact us at:
Print Abstract
For additional information on this study or to purchase, please call:
|
Survey
Other |